Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use

dc.contributor.authorComoglu, Tansel
dc.contributor.authorOzyilmaz, Emine Dilek
dc.date.accessioned2026-02-06T18:47:01Z
dc.date.issued2019
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractThe oral administration route is considered to be the most widely used route because of its convenience of administration and manufacturing. Dosage forms, like orally disintegrating tablets (ODTs), mini tablets, and orally disintegrating mini tablets (ODMTs), are recognized as promising for use in pediatric patients. ODTs are known to be suitable drug delivery systems, especially for pediatric patients, because of their rapid disintegration properties, use without water, and no swallowing problems. In addition, in recent years, a new formulation approach has been developed. ODMTs, are the newest drug delivery systems. They combine the advantageous properties of ODTs and the small size of mini tablets, aimed for pediatric use. These tablets, which can be formulated as 2-4mm in diameter, are known as drug delivery systems that have children acceptability age as low as 6-months old. The fact that the ODTs and the ODMTs can be formulated with acceptable flavors for children further increases the importance of these carrier systems in the treatment. The objective of this article is to highlight the development of ODTs and mini-ODTs, their significance, ideal characteristics, various techniques, and aspects related to design and formulation, marketed preparations, and future perspectives, especially for the pediatric patients.
dc.identifier.doi10.1080/10837450.2019.1615090
dc.identifier.endpage914
dc.identifier.issn1083-7450
dc.identifier.issn1097-9867
dc.identifier.issue7
dc.identifier.pmid31215850
dc.identifier.scopus2-s2.0-85067627652
dc.identifier.scopusqualityQ2
dc.identifier.startpage902
dc.identifier.urihttps://doi.org/10.1080/10837450.2019.1615090
dc.identifier.urihttps://hdl.handle.net/11129/14193
dc.identifier.volume24
dc.identifier.wosWOS:000473511100010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofPharmaceutical Development and Technology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectPediatric formulations
dc.subjectorally disintegrating tablets
dc.subjectadvantages
dc.subjectlimitations
dc.subjectpreparation method
dc.subjectquality controls of orally disintegrating mini tablets
dc.titleOrally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use
dc.typeReview Article

Files